Retrospective Study
Copyright ©The Author(s) 2021.
World J Radiol. Dec 28, 2021; 13(12): 371-379
Published online Dec 28, 2021. doi: 10.4329/wjr.v13.i12.371
Table 1 Baseline demographics
Variable
Summary (n = 65)
Median age in years (interquartile range)54 (41-63)
Median BMI in kg/m2 (interquartile range)28 (25.1-32.7)
Gender
Male38 (58.5%)
Female27 (41.5%)
Clinical symptoms
Lower extremity swelling57 (87.7%)
Lower extremity pain44 (67.7%)
Venous stasis ulceration7 (10.8%)
Varicose veins3 (4.6%)
Pelvic pain2 (3.1%)
Symptomatic side
Left49 (75.4%)
Right14 (21.5%)
Bilateral2 (3.1%)
Thrombophilia risk factor
Young age (< 40 yr)24 (35.9%)
Family history12 (18.5%)
Unprovoked 16 (24.6%)
VTE provoking factor
Prolonged immobilization15 (23.1%)
Malignancy13 (20.0%)
Recent surgery5 (7.7%)
Trauma5 (7.7%)
Pregnancy7 (14.6%)
Hormonal supplement4 (6.2%)
None16 (24.6%)
Table 2 Procedure details
Variable
Summary (n = 65)
Pre-procedure CIV patency
Stenosis47 (72.3%)
Occlusion16 (24.6%)
In-stent thrombosis2 (3.1%)
Stent location
Left CIV50 (76.9%)
Right CIV11 (16.9%)
Bilateral CIV4 (6.2%)
Stent type
Wallstent51 (78.5%)
Venovo9 (13.8%)
Smart2 (3.1%)
Vici3 (4.6%)
CIV stent balloon dilation diameter (mm)
121 (1.5%)
1414 (21.5%)
1628 (43.1%)
1819 (29.2%)
203 (4.6%)
Additional stented segments
External iliac vein54 (83.1%)
Common femoral vein45 (69.2%)
Simultaneous endovascular interventions
Thrombolysis25 (38.5%)
Thrombectomy17 (26.2%)
CIV filter retrieval3 (4.6%)
Table 3 Complications by thrombophilia testing
Thrombophilia work-up (n = 33)
Positive (n = 16)
Negative (n = 17)
Clinical success
Stent patency14 (87.5%)12 (70.6%)
1 mo12 of 13 (92.3%)13 of 16 (81.3%)
6 mo10 of 12 (83.3%)12 of 15 (80%)
12 mo 7 of 9 (77.8%)10 of 13 (76.9%)
Stent thrombosis2 (12.5%)4 (23.5%)
Anticoagulated during stent thrombosis1 of 2 (50%)2 of 4 (50%)
Re-intervention rates4 (25%)6 (35.3%)
Number of re-interventions
150%67%
20%33%
325%0%
425%0%